Sage Therapeutics
Based in MA
AI Overview
With $4.8M in lobbying spend across 28 quarterly filings, Sage Therapeutics is a significant lobbying presence. Their lobbying covers 7 issue areas. Active from 2019 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $589K |
| 2020 | $895K |
| 2021 | $1.0M |
| 2022 | $1.2M |
| 2023 | $510K |
| 2024 | $570K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Sage Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Copyright/Patent, Health Issues, Pharmacy and 2 more
Maternal Mental Health
Major Depressive Disorder
Mental Illness
Drug Pricing
Drug Price Transparency
Medicaid Reform
Medicare Reform
Insurance Coverage
Value Based Care
IP Reform
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.